NO960268L - Nye dialkoksypyridinylbenzimidazolderivater - Google Patents
Nye dialkoksypyridinylbenzimidazolderivaterInfo
- Publication number
- NO960268L NO960268L NO960268A NO960268A NO960268L NO 960268 L NO960268 L NO 960268L NO 960268 A NO960268 A NO 960268A NO 960268 A NO960268 A NO 960268A NO 960268 L NO960268 L NO 960268L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- methyl
- new
- dialkoxypyridinylbenzimidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Nye optisk rene forbindelser, dvs de enantiomere enkeltforbindelsene (+)-5- karbometoksy-6-metyl-2-[[(3,4-dimetoksy-2-pyridinyl)metyl]sulfmyl]-l-[mandel- oyloksymetyl]-! H-benzimidazol og (-)-5-karbometoksy-6-metyl-2-[[(3,4-dimetoksy-2- pyridinyl)metyl]sulfinyl]-1 -[mandeloyloksymetyl]-1 H-benzimidazol eller et terapeutisk akseptabelt salt derav, slik som Na+, Mg2+, Li+, K+, Ca2+og N+(R)4 salter, hvor R er en alkylgruppe med 1-4 karbonatomer, fremgangsmåter for fremstilling derav og farma- søytiske preparater inneholdende forbindelsene som aktive bestanddeler, anvendelse av forbindelsene i farmasøytiske preparater samt mellomprodukter oppnådd ved frem- ' stilling av forbindelsene.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25617194A | 1994-05-27 | 1994-05-27 | |
SE9400511 | 1994-05-27 | ||
PCT/SE1995/000519 WO1995032959A1 (en) | 1994-05-27 | 1995-05-11 | Novel dialkoxy-pyridinyl-benzimidazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960268L true NO960268L (no) | 1996-01-23 |
NO960268D0 NO960268D0 (no) | 1996-01-23 |
Family
ID=20392945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960268A NO960268D0 (no) | 1994-05-27 | 1996-01-23 | Nye dialkoksypyridinylbenzimidazolderivater |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0712401A1 (no) |
JP (1) | JPH09504557A (no) |
CN (1) | CN1128997A (no) |
AU (1) | AU2633095A (no) |
BR (1) | BR9506235A (no) |
CA (1) | CA2166988A1 (no) |
CZ (1) | CZ24396A3 (no) |
EE (1) | EE9600011A (no) |
FI (1) | FI960367A0 (no) |
HU (1) | HU9600005D0 (no) |
IL (1) | IL113604A0 (no) |
IS (1) | IS4321A (no) |
MA (1) | MA23563A1 (no) |
NO (1) | NO960268D0 (no) |
PL (1) | PL312692A1 (no) |
TN (1) | TNSN95062A1 (no) |
WO (1) | WO1995032959A1 (no) |
ZA (1) | ZA954125B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
IL142629A0 (en) * | 1998-11-18 | 2002-03-10 | Astra Ab | Improved chemical process and pharmaceutical formulation |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP2486910A3 (en) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Multi-chambered apparatus comprising a dispenser head |
EP2252274A4 (en) | 2008-02-20 | 2011-05-11 | Univ Missouri | COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME |
CA2736547C (en) | 2008-09-09 | 2016-11-01 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
MX2014007935A (es) | 2011-12-28 | 2014-11-14 | Pozen Inc | Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL166209B1 (pl) * | 1990-06-20 | 1995-04-28 | Astra Ab | Sposób wytwarzania nowych pochodnych benzimidazolu PL |
DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
-
1994
- 1994-05-29 TN TNTNSN95062A patent/TNSN95062A1/fr unknown
-
1995
- 1995-05-03 IL IL11360495A patent/IL113604A0/xx unknown
- 1995-05-11 EE EE9600011A patent/EE9600011A/xx unknown
- 1995-05-11 BR BR9506235A patent/BR9506235A/pt not_active Application Discontinuation
- 1995-05-11 CN CN95190482A patent/CN1128997A/zh active Pending
- 1995-05-11 PL PL95312692A patent/PL312692A1/xx unknown
- 1995-05-11 WO PCT/SE1995/000519 patent/WO1995032959A1/en not_active Application Discontinuation
- 1995-05-11 EP EP95921187A patent/EP0712401A1/en not_active Withdrawn
- 1995-05-11 AU AU26330/95A patent/AU2633095A/en not_active Abandoned
- 1995-05-11 JP JP8500730A patent/JPH09504557A/ja active Pending
- 1995-05-11 HU HU9600005A patent/HU9600005D0/hu unknown
- 1995-05-11 CA CA002166988A patent/CA2166988A1/en not_active Abandoned
- 1995-05-11 CZ CZ96243A patent/CZ24396A3/cs unknown
- 1995-05-19 ZA ZA954125A patent/ZA954125B/xx unknown
- 1995-05-26 MA MA23901A patent/MA23563A1/fr unknown
-
1996
- 1996-01-17 IS IS4321A patent/IS4321A/is unknown
- 1996-01-23 NO NO960268A patent/NO960268D0/no unknown
- 1996-01-26 FI FI960367A patent/FI960367A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ24396A3 (en) | 1996-06-12 |
TNSN95062A1 (fr) | 1996-02-06 |
WO1995032959A1 (en) | 1995-12-07 |
FI960367A (fi) | 1996-01-26 |
CN1128997A (zh) | 1996-08-14 |
PL312692A1 (en) | 1996-05-13 |
ZA954125B (en) | 1995-11-27 |
AU2633095A (en) | 1995-12-21 |
MA23563A1 (fr) | 1995-12-31 |
CA2166988A1 (en) | 1995-12-07 |
IL113604A0 (en) | 1995-08-31 |
HU9600005D0 (en) | 1996-03-28 |
JPH09504557A (ja) | 1997-05-06 |
EE9600011A (et) | 1996-04-15 |
IS4321A (is) | 1996-01-17 |
BR9506235A (pt) | 1997-08-12 |
FI960367A0 (fi) | 1996-01-26 |
NO960268D0 (no) | 1996-01-23 |
EP0712401A1 (en) | 1996-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY121192A (en) | New compounds. | |
NO960268L (no) | Nye dialkoksypyridinylbenzimidazolderivater | |
NO160204C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkalisalter av 5-metoksy-2(((4-metoksy-3,5-dimetyl-2-pyridinyl)-metyl)-sulfinyl)-1h-benzimidazol. | |
FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
ATE698T1 (de) | Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. | |
NO171915C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azabicyklo(4.2.0)okt-2-en-derivater | |
NO178338C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse samt mellomprodukt | |
IL92799A0 (en) | Benzimidazole derivatives with gastric acid inhibition and process for its preparation | |
AU7817087A (en) | 2-(thio-linked)-pyridine-5-(4,5-dihydro-2-oxazolyl)-(thieno( 2,3-d)-imidazoles and -benzimidazoles), a process for their preparation, and their use | |
ES8100263A1 (es) | Procedimiento para preparar un derivado de acido 1-bencil-1,2,5,6-tetrahidropiridina-3-carboxilico | |
NO960267L (no) | Nye substituerte benzimidazoler | |
ES8303418A1 (es) | Un procedimiento para la preparacion de derivados de benzo (4,5 pinano 2,3c) pirrol. | |
JO1871B1 (en) | Innovative substituted benzimidazole compounds | |
JO1870B1 (en) | CO2 derivatives - pyridinyl benzimidazole innovative | |
EP0192393A3 (en) | Alkylaminofuranone derivatives | |
FI893570A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi | |
AU617849B2 (en) | New benzopyrrolidinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them | |
DE69000806D1 (de) | Indol-derivate. | |
HUT42093A (en) | Process for preparing 2-/2-thienyl/-imidazo/4,5-e/pyridine derivatives ang pharmaceutically acceptable acid addition salts thereof | |
DK210387D0 (da) | Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse |